Gilead Sciences, Inc. (GILD) operating KPIs
GILDNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 6, 2026Score 11/30105% above fair value
$170.68+5.07 (+3.06%)
Close on Oct 30, 2026Market cap $211.64BP/E –Yield 1.85%
Gilead Sciences u.S. PCE: Pharmaceutical and Other Medical Products ($B SAAR)
FRED (DHLCRC1Q027SBEA)
Latest, Q2 2026
3,790.30
Period ended Jun 30, 2026
Change on a year earlier
+7.4%
3,529.80 in Q2 2025
History
42 quarters
Since Q1 2016
Sources
1
FRED (DHLCRC1Q027SBEA)
Quarterly history
Hover a value to see the sentence it was read from; calculated values show their formula
| Period | Ended | U.S. PCE: Pharmaceutical and Other Medical Products ($B SAAR) | Year on year | Source |
|---|---|---|---|---|
| Q2 2026 | Jun 30, 2026 | 3,790.30 | +7.4% | FRED (DHLCRC1Q027SBEA) ↗ |
| Q1 2026 | Mar 31, 2026 | 3,699.90 | +6.8% | FRED (DHLCRC1Q027SBEA) ↗ |
| Q4 2025 | Dec 31, 2025 | 3,667.00 | +7.3% | FRED (DHLCRC1Q027SBEA) ↗ |
| Q3 2025 | Sep 30, 2025 | 3,614.80 | +7.6% | FRED (DHLCRC1Q027SBEA) ↗ |
| Q2 2025 | Jun 30, 2025 | 3,529.80 | +7.3% | FRED (DHLCRC1Q027SBEA) ↗ |
| Q1 2025 | Mar 31, 2025 | 3,464.70 | +6.8% | FRED (DHLCRC1Q027SBEA) ↗ |
| Q4 2024 | Dec 31, 2024 | 3,417.80 | +8.2% | FRED (DHLCRC1Q027SBEA) ↗ |
| Q3 2024 | Sep 30, 2024 | 3,358.20 | +9.1% | FRED (DHLCRC1Q027SBEA) ↗ |
| Q2 2024 | Jun 30, 2024 | 3,288.20 | +8.3% | FRED (DHLCRC1Q027SBEA) ↗ |
| Q1 2024 | Mar 31, 2024 | 3,244.40 | +8.8% | FRED (DHLCRC1Q027SBEA) ↗ |
| Q4 2023 | Dec 31, 2023 | 3,159.40 | +8.7% | FRED (DHLCRC1Q027SBEA) ↗ |
| Q3 2023 | Sep 30, 2023 | 3,079.00 | +8.4% | FRED (DHLCRC1Q027SBEA) ↗ |
| Q2 2023 | Jun 30, 2023 | 3,034.80 | +9.5% | FRED (DHLCRC1Q027SBEA) ↗ |
| Q1 2023 | Mar 31, 2023 | 2,982.50 | +8.3% | FRED (DHLCRC1Q027SBEA) ↗ |
| Q4 2022 | Dec 31, 2022 | 2,907.00 | +6.5% | FRED (DHLCRC1Q027SBEA) ↗ |
| Q3 2022 | Sep 30, 2022 | 2,839.30 | +5.9% | FRED (DHLCRC1Q027SBEA) ↗ |
| Q2 2022 | Jun 30, 2022 | 2,771.70 | +5.6% | FRED (DHLCRC1Q027SBEA) ↗ |
| Q1 2022 | Mar 31, 2022 | 2,754.90 | +8.7% | FRED (DHLCRC1Q027SBEA) ↗ |
| Q4 2021 | Dec 31, 2021 | 2,728.80 | +8.8% | FRED (DHLCRC1Q027SBEA) ↗ |
| Q3 2021 | Sep 30, 2021 | 2,680.70 | +11.3% | FRED (DHLCRC1Q027SBEA) ↗ |
| Q2 2021 | Jun 30, 2021 | 2,624.30 | +27.5% | FRED (DHLCRC1Q027SBEA) ↗ |
| Q1 2021 | Mar 31, 2021 | 2,534.30 | +3.7% | FRED (DHLCRC1Q027SBEA) ↗ |
| Q4 2020 | Dec 31, 2020 | 2,507.60 | -0.9% | FRED (DHLCRC1Q027SBEA) ↗ |
| Q3 2020 | Sep 30, 2020 | 2,408.10 | -3.1% | FRED (DHLCRC1Q027SBEA) ↗ |
| Q2 2020 | Jun 30, 2020 | 2,057.70 | -16.2% | FRED (DHLCRC1Q027SBEA) ↗ |
| Q1 2020 | Mar 31, 2020 | 2,443.30 | +0.9% | FRED (DHLCRC1Q027SBEA) ↗ |
| Q4 2019 | Dec 31, 2019 | 2,529.30 | +6.9% | FRED (DHLCRC1Q027SBEA) ↗ |
| Q3 2019 | Sep 30, 2019 | 2,484.70 | +4.9% | FRED (DHLCRC1Q027SBEA) ↗ |
| Q2 2019 | Jun 30, 2019 | 2,454.40 | +5.2% | FRED (DHLCRC1Q027SBEA) ↗ |
| Q1 2019 | Mar 31, 2019 | 2,421.20 | +4.8% | FRED (DHLCRC1Q027SBEA) ↗ |
| Q4 2018 | Dec 31, 2018 | 2,366.40 | +3.8% | FRED (DHLCRC1Q027SBEA) ↗ |
| Q3 2018 | Sep 30, 2018 | 2,369.10 | +5.1% | FRED (DHLCRC1Q027SBEA) ↗ |
| Q2 2018 | Jun 30, 2018 | 2,334.00 | +5.0% | FRED (DHLCRC1Q027SBEA) ↗ |
| Q1 2018 | Mar 31, 2018 | 2,309.50 | +3.9% | FRED (DHLCRC1Q027SBEA) ↗ |
| Q4 2017 | Dec 31, 2017 | 2,280.70 | +3.7% | FRED (DHLCRC1Q027SBEA) ↗ |
| Q3 2017 | Sep 30, 2017 | 2,254.80 | +4.1% | FRED (DHLCRC1Q027SBEA) ↗ |
| Q2 2017 | Jun 30, 2017 | 2,222.40 | +2.6% | FRED (DHLCRC1Q027SBEA) ↗ |
| Q1 2017 | Mar 31, 2017 | 2,223.30 | +4.5% | FRED (DHLCRC1Q027SBEA) ↗ |
| Q4 2016 | Dec 31, 2016 | 2,199.80 | – | FRED (DHLCRC1Q027SBEA) ↗ |
| Q3 2016 | Sep 30, 2016 | 2,165.60 | – | FRED (DHLCRC1Q027SBEA) ↗ |
| Q2 2016 | Jun 30, 2016 | 2,165.40 | – | FRED (DHLCRC1Q027SBEA) ↗ |
| Q1 2016 | Mar 31, 2016 | 2,127.80 | – | FRED (DHLCRC1Q027SBEA) ↗ |
Cite this data
StockData. (2026). Gilead Sciences U.S. PCE: Pharmaceutical and Other Medical Products ($B SAAR), quarterly Q1 2016–Q2 2026 [Data set]. Compiled from Gilead Sciences SEC filings and investor materials. https://stockdatahq.com/stocks/gild/kpis/fred_pce_pharma
See every metric in the Gilead Sciences KPI table. Data updated Oct 29, 2026.